These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6575725)
21. Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy. Clark RH; Dimitrov NV; Axelson JA; Charamella LJ J Biol Response Mod; 1984 Dec; 3(6):613-9. PubMed ID: 6512561 [TBL] [Abstract][Full Text] [Related]
22. [Second neoplasms in malignant hematologic disorders. Experience from 1978 to 1987]. Cristoffanini A; Zapata C; León A; Salas P Rev Med Chil; 1990 May; 118(5):522-9. PubMed ID: 2293272 [TBL] [Abstract][Full Text] [Related]
23. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases]. Ezaki K Gan No Rinsho; 1983 May; 29(6):598-602. PubMed ID: 6308306 [No Abstract] [Full Text] [Related]
24. Interferon-alpha: current status and future promise. Bonnem EM; Spiegel RJ J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483 [No Abstract] [Full Text] [Related]
25. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2). Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074 [TBL] [Abstract][Full Text] [Related]
26. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
27. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies]. Imamura Y Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002 [No Abstract] [Full Text] [Related]
28. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Early AP; Preisler HD; Slocum H; Rustum YM Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642 [TBL] [Abstract][Full Text] [Related]
29. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy. Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686 [TBL] [Abstract][Full Text] [Related]
30. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit]. Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436 [TBL] [Abstract][Full Text] [Related]
31. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies]. Takeyama H; Yano K; Kataoka T; Watanabe E; Kobayashi M; Ohno R Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741 [No Abstract] [Full Text] [Related]
32. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Reich G; Mapara MY; Reichardt P; Dörken B; Maschmeyer G Bone Marrow Transplant; 2001 Mar; 27(5):525-9. PubMed ID: 11313687 [TBL] [Abstract][Full Text] [Related]
33. [Study of some aspects of the problem of leukemias and bone marrow transplantation in France]. Faĭnshteĭn FE; Reshchikov VP Probl Gematol Pereliv Krovi; 1977 Nov; (11):56-8. PubMed ID: 339227 [No Abstract] [Full Text] [Related]
34. Treatment of lymphoid neoplasias with interferon. I. Human fibroblastic beta-interferon in malignant gammapathies. Phase II trial. Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval T; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; De Vassal F; Horoszewicz JS Anticancer Res; 1982; 2(1-2):63-6. PubMed ID: 6180675 [TBL] [Abstract][Full Text] [Related]
35. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse. Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346 [TBL] [Abstract][Full Text] [Related]
36. Biotherapy with interferon in hematologic malignancies. Roth MS; Foon KA Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569 [No Abstract] [Full Text] [Related]
37. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases. Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR Acta Haematol Pol; 1980; 11(3):165-71. PubMed ID: 6449819 [No Abstract] [Full Text] [Related]
38. Serum ferritin levels in hematologic malignant neoplasms. Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189 [TBL] [Abstract][Full Text] [Related]
39. [Indications, technique and risks in bone marrow transplantation in adulthood]. Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901 [TBL] [Abstract][Full Text] [Related]
40. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan]. Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]